Back to search

Peptide record

TPDB07505

Antibacterial Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07505
Antibacterial Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia PD_Hemolysis
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Hemolysis, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LKLKAIAALAKKKW
Physicochemical Analysis
C77H136N20O15
RNDCEQGHMFPSTYV
K
1582.05
11.12
5
0
9
+5
0.43
0.193
140.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
5500
347.65
0
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
3
L
5
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 3 K: 5 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
14
C77H136N20O15
1582.05
11.12
+5
0.43
0.193
Evidence Records 5 records
Evidence 1 Activity

Activity

5% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. | Chem Biol Drug Des | 2016
Evidence 2 Activity

Activity

18% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
18% Hemolysis | 64 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. | Chem Biol Drug Des | 2016
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. | Chem Biol Drug Des | 2016
Evidence 4 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.27591703] 0% hemolysis at 64 µg/ml against human red blood cells 0% hemolysis at 16 µg/ml , 2.5% hemolysis at 32 µg/ml , 10% hemolysis at 64 µg/ml against sheep red blood cells | Cytotoxicity: [Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.9%, 95.4%, 89.7%, 83.4%, 83.1%, 73.7% and 71.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 µg/mL within 24h.

Target

erythrocytes

Source & Reference

NA
DRAMP
Chem Biol Drug Des. 2017 Mar 89(3):327-338. doi: 10.1111/cbdd.12864.
Evidence 5 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis